Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib in advanced GIST
NCT01323400Phase 2Completed
- Sponsor
- Centre Léon Bérard
- Start
- Mar 2011
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pazopanib in gastrointestinal stromal tumor (GIST), sponsored by Centre Léon Bérard. Started Mar 2011; status: completed.
02
Drugs
pazopanib
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT01323400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01323400.